Preview Mode Links will not work in preview mode

Listen to articles here or read at ContrarianEdge.com / To learn more about investment services, visit imausa.com

Dec 8, 2020

In this interview with Andrew Kleuss on Investors Hub, Vitaliy makes the case that concerns over Amazon's entry into the pharmaceuticals business are probably overblown. To parse this problem, Vitaliy differentiates between pharmacies and drug distributors, and analyzes the extent to which Amazon can compete with both. While Amazon might place some pressure on pharmacies over time, he explains how drug distributors' unique supply chains should remain robust against a competitive threat from Amazon.